COVID-19’s impact on the global economy has ramifications for businesses looking to raise money or maintain growth through acquisitions. The first quarter of this year has seen a marked drop in the volume of M&A deals. The venture financing landscape in Q1, on the other hand, seems to be holding steady and saw deal volume and value hit its highest level in the last five years. According to David Mardle, a partner in Goodwin’s Life Sciences and Technology groups, lead investors are pushing hard to accelerate the syndication process as the COVID-19 crisis deepened and spread across the globe. Read the article in FirstWord MedTech here.